News
11-17-2008, 09:21 PM
Siemens Healthcare ( www.siemens.com/diagnostics ) announced that data from a new study published in the American Cancer Society journal Cancer, supports using the Siemens Serum HER-2/neu test to monitor patients with an aggressive type of metastatic breast cancer.
More... (http://www.news-medical.net/?id=43034)
More... (http://www.news-medical.net/?id=43034)